×
About 5,190 results

ALLMedicine™ Valvular Heart Disease Center

Research & Reviews  1,502 results

Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032139
Vascular Health and Risk Management; Al-Najar M, Al-Nusair M et. al.

Mar 28th, 2023 - The risks of thromboembolism and major bleeding in atrial fibrillation (AF) patients were assessed according to the "Evaluated Heartvalves, Rheumatic or Artificial" (EHRA) classification. Additionally, the safety and efficacy of vitamin K antagoni...

Diagnostic accuracy of heart auscultation for detecting valve disease: a systematic rev...
https://doi.org/10.1136/bmjopen-2022-068121
BMJ Open; Davidsen AH, Andersen S et. al.

Mar 25th, 2023 - The objective of this study was to determine the diagnostic accuracy in detecting valvular heart disease (VHD) by heart auscultation, performed by medical doctors. A systematic literature search for diagnostic studies comparing heart auscultation ...

Fully Automated Artificial Intelligence Assessment of Aortic Stenosis by Echocardiography.
https://doi.org/10.1016/j.echo.2023.03.008
Journal of the American Society of Echocardiography : Off... Krishna H, Desai K et. al.

Mar 24th, 2023 - Aortic stenosis (AS) is a common form of valvular heart disease, present in over 12% of the population aged 75 years and above1. Transthoracic echocardiography (TTE) is the first line of imaging in the adjudication of AS severity but is time consu...

Simultaneous Live Donor Liver Transplantation, Aortic Valve Replacement, and Atrial Sep...
https://doi.org/10.1016/j.transproceed.2023.02.027
Transplantation Proceedings; Kazimi M, Beydullayev K et. al.

Mar 24th, 2023 - Valvular heart disease creates an important barrier for orthotopic liver transplantation in patients with end-stage liver disease and increases mortality. Selection of the appropriate surgical scheme and adequate postoperative management can be li...

Early Aortic vaLve surgEry Versus wAtchful waitiNg Strategy in Severe Asymptomatic aOrtic reguRgitation
https://clinicaltrials.gov/ct2/show/NCT05438862

Mar 23rd, 2023 - Introduction: Aortic regurgitation (AR) is the third most frequent valvular heart disease in Western countries affecting rather young patients, mostly men. The degenerative process on the trileaflet aortic valve is the main cause of AR, followed b...

see more →

Guidelines  20 results

ACR Appropriateness Criteria® Dyspnea-Suspected Cardiac Origin (Ischemia Already Exclud...
https://doi.org/10.1016/j.jacr.2022.02.014
Journal of the American College of Radiology : JACR; , Bolen MA et. al.

May 14th, 2022 - Dyspnea is the symptom of perceived breathing discomfort and is commonly encountered in a variety of clinical settings. Cardiac etiologies of dyspnea are an important consideration; among these, valvular heart disease (Variant 1), arrhythmia (Vari...

2020 ACC/AHA guideline for the management of patients with valvular heart disease: A re...
https://doi.org/10.1016/j.jtcvs.2021.04.002
The Journal of Thoracic and Cardiovascular Surgery; , Otto CM et. al.

May 12th, 2021 - 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2021| ,Otto CM,Nishimura RA,Bonow RO,Cara...

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Exec...
https://doi.org/10.1016/j.jacc.2020.11.035
Journal of the American College of Cardiology; , Otto CM et. al.

Dec 22nd, 2020 - This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. A comprehensive literature search was ...

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Exec...
https://doi.org/10.1161/CIR.0000000000000932
Circulation Otto CM, Nishimura RA et. al.

Dec 18th, 2020 - This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. A comprehensive literature search was ...

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Re...
https://doi.org/10.1161/CIR.0000000000000923
Circulation Otto CM, Nishimura RA et. al.

Dec 18th, 2020 - 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.|2020|Otto CM,Nishimura RA,Bonow RO,Carabe...

see more →

Drugs  75 results see all →

Clinicaltrials.gov  182 results

Early Aortic vaLve surgEry Versus wAtchful waitiNg Strategy in Severe Asymptomatic aOrtic reguRgitation
https://clinicaltrials.gov/ct2/show/NCT05438862

Mar 23rd, 2023 - Introduction: Aortic regurgitation (AR) is the third most frequent valvular heart disease in Western countries affecting rather young patients, mostly men. The degenerative process on the trileaflet aortic valve is the main cause of AR, followed b...

Use of Artificial Intelligence-Guided Echocardiography to assIst cardiovascuLar Patient managEment
https://clinicaltrials.gov/ct2/show/NCT05558605

Mar 3rd, 2023 - Heart Failure (HF) and valvular heart disease (VHD) are disproportionate problems in rural and remote Australia (RRA) relative to the rest of the country, due in part to an ageing rural population and to the frequency of rheumatic heart disease in...

Randomized Study for the Optimal Treatment of Symptomatic Patients With Low Gradient Severe Aortic Valve Stenosis and Preserved Left Ventricular Ejection Fraction
https://clinicaltrials.gov/ct2/show/NCT03667365

Mar 1st, 2023 - According to current European Recommendations on valvular heart disease (VHD), "classical" severe aortic stenosis (AS) is defined by an aortic valve area (AVA) ≤1 cm2 and indexed AVA ≤0.6 cm2/m2, a mean aortic pressure gradient (MAG) >40 mmHg, and...

Progesterone Containing Contraceptive Methods on Endogenous Progesterone Level
https://clinicaltrials.gov/ct2/show/NCT05742503

Feb 24th, 2023 - Progestogen-only' contraceptives are presented as injections, implants, oral formulations, hormone-releasing intrauterine methods and emergency contraceptives. These substances could be used by females who are breastfeeding or have other contraind...

Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE
https://clinicaltrials.gov/ct2/show/NCT03488420

Feb 22nd, 2023 - This is an observational, prospective, multicenter, edoxaban Canadian registry of adults (≥18) diagnosed or confirmed with AF and/or AFL with VHD, within the last 12 months, according to local standard procedures and judged by the investigator to ...

see more →

News  274 results

Aortic Disease Clinical Practice Guidelines (ACC/AHA, 2022)
https://www.medscape.com/viewarticle/985190

Dec 9th, 2022 - Guidelines on the diagnosis and management of aortic disease were published in November 2022 by the American College of Cardiology (ACC) and the American Heart Association (AHA) in Circulation.[1,2,3,4,5] These recommendations replace the 2010 ACC...

ACC/AHA Issues Updated Guidance on Aortic Disease
https://www.medscape.com/viewarticle/983473

Nov 3rd, 2022 - The American College of Cardiology (ACC) and the American Heart Association (AHA) have published an updated guideline on the diagnosis and management of aortic disease, focusing on surgical intervention considerations, consistent imaging practices...

Management of antithrombotic medications in elective endoscopy
https://www.mdedge.com/gihepnews/article/258808/endoscopy/management-antithrombotic-medications-elective-endoscopy
Wenfei Wang, MD, Neil Sengupta, MD

Nov 1st, 2022 - Antithrombotic therapy is increasingly used to either reduce the risk of or treat thromboembolic episodes in patients with various medical conditions such as ischemic and valvular heart disease, atrial fibrillation (AF), cerebrovascular disease, p.

Apixaban outmatches rivaroxaban in patients with AFib and valvular heart disease
https://www.mdedge.com/internalmedicine/article/258703/cardiology/apixaban-outmatches-rivaroxaban-patients-afib-and
Will Pass

Oct 18th, 2022 - Apixaban offers greater protection than rivaroxaban against ischemic stroke, systemic embolism, and bleeding in patients with both atrial fibrillation (AFib) and valvular heart disease (VHD), a new study finds. Compared with rivaroxaban, apixaban c.

SPRINT BP Control Benefit Fizzles Out; Hot Flashes and CVD; Metformin for Afib?
https://www.medpagetoday.com/cardiology/prevention/101276

Oct 18th, 2022 - In a new policy statement, the American College of Cardiology endorsed more flexible hours and work arrangements so that cardiologists and trainees can have a better work-life balance. High-intensity care following heart failure (HF) hospitalizati...

see more →

Patient Education  23 results see all →